Displaying 51–75 of 797 results for Packaging
Life sciences companies look to utility savings, collaborative product development and serialization to go green according to Tom Egan, Vice President, Industry Services, PMMI, The Association for Packaging and Processing Technologies
Data is changing the pharma operations world by turning a buzzword into exponential impact.
Digitization will require significant investment but will pay off in protection from counterfeits, cheaper recalls and improved production and inventory management
Sourcing high quality APIs in a cost and time efficient manner requires a detailed understanding of manufacturing regulations and global supply chains
Selecting the right vendor is critical for young companies. Here are six essential steps for making sure your company makes the right choice.
The needs of smaller companies must be addressed when discussing transformative processes
Today’s solid dose manufacturing reality still relies on skillful execution by operators
Industry experts weigh in on the application and value of Overall Equipment Effectiveness in pharma
China’s recent regulatory changes will positively impact global innovative drug development
Pharma leaders advocate standardized identification of investigational products to improve efficiency and safety in clinical trials
Atrium improves audits and complaints, change control, and product release processes with immediate access to information and operational visibility
Pharma companies that embrace a digital factory approach will see improvements in data availability, visibility and decision-making
Paul Moscrop, Process Engineering Manager at Sterling Pharma Solutions on the growing demand for hazardous chemistry brings new risks that require both chemistry and engineering expertise.
The latest tech and tricks for purchasing the best mixing equipment.
How the emerging technology could be pharma's savior from costly regulations and counterfeit drugs.
How Pharmavite streamlined operations and boosted capacity from existing assets
By many measures, the legal, regulatory and market fallout from opioids has just begun.
Why M&A may dominate the 2018 biopharma contract manufacturing landscape and the future may depend on the industry’s response to consolidation.
Contract Manufacturing & Development's Big Pharma Ascendency
CDMOs perfect the art of survival in today’s multi-product world
Product Focus: Single-Use Technologies
Staying on Track for Drug Safety: Future electronic tracking and tracing system will shore up safety of drug supply chain.
Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply – where does the industry stand?
All the major changes this year including guidance documents drafted and finalized, new legislation, other areas of interest and some tools to help you explore additional areas not covered herein but might be of interest to you; the impact of these changes is provided for some of the information.
Asset intelligence gives cGMP manufacturers a new way to harness the information they need to prove manufacturing compliance